0 results available. Select is focused ,type to refine list, press Down to open the menu,
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The ...
The following section summarizes insights on Vaccinex Inc's Price / Sales Growth Ratio:
We've identified the following companies as similar to Vaccinex Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Price / Sales Growth Ratio in the valuation category include:
A heuristic used to measure the level of revenue growth relative to the Price / Sales multiple.
The chart above depicts the distribution of price / sales growth ratio for companies operating in the Healthcare sector in the Developed economic region. Over 1,530 companies were considered in this analysis, and 1,475 had meaningful values. The average price / sales growth ratio of companies in the sector is 0.6 with a standard deviation of 1.8.
Vaccinex Inc's Price / Sales Growth Ratio of 0.0 ranks in the 12.1% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,537 |
| Included Constituents | 1,475 |
| Min | 0.0 |
| Max | 18.5 |
| Median | 0.1 |
| Mean | 0.6 |
| Standard Deviation | 1.8 |
You can find companies with similar price / sales growth ratio using this stock screener.